DBV Technologies - Aktienkurs

Aktienkurs
4.18
Täglich Wechseln
-0.30 -6.72%
Monatlich
-0.46%
Jährlich
386.66%
Q1 Prognose
4.15


Preis Chg Tag Jahr Datum
Acadia Pharmaceuticals 17.56 -0.05 -0.28% -25.09% 2025-03-07
Alnylam Pharmaceuticals 244.52 -3.61 -1.45% 63.21% 2025-03-07
Amarin 0.53 -0.004 -0.80% -42.58% 2025-03-07
BioMarin Pharmaceutical 72.23 1.02 1.43% -15.96% 2025-03-07
DBV Technologies 4.18 -0.30 -6.72% 386.66% 2025-03-07
Halozyme Therapeutics 60.98 0.83 1.38% 46.13% 2025-03-07
Incyte 70.79 0.70 1.00% 17.94% 2025-03-07
Insmed 74.89 -0.13 -0.17% 169.19% 2025-03-07
Ionis Pharmaceuticals 33.81 -0.58 -1.69% -23.14% 2025-03-07
Neurocrine Biosciences 113.04 0.38 0.34% -18.80% 2025-03-07
PTC Therapeutics 52.59 -0.21 -0.40% 68.77% 2025-03-07
Ultragenyx Pharmaceutical 38.62 -1.40 -3.50% -23.57% 2025-03-07
Sarepta Therapeutics 103.03 -2.53 -2.40% -17.16% 2025-03-07
United Therapeutics 315.91 8.23 2.67% 29.98% 2025-03-07

Preis Tag Jahr Datum
USND 18196 126.97 0.70% 13.12% 2025-03-07